SU9516 - CDK 抑制剂 - 生命科学试剂 - MedChemExpress_第1页
SU9516 - CDK 抑制剂 - 生命科学试剂 - MedChemExpress_第2页
SU9516 - CDK 抑制剂 - 生命科学试剂 - MedChemExpress_第3页
SU9516 - CDK 抑制剂 - 生命科学试剂 - MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemESU9516Cat. No.: HY-18629CAS No.: 377090-84-1分式: CHNO分量: 241.25作靶点: CDK; Autophagy作通路: Cell Cycle/DNA Damage; Autophagy储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 100 mg/mL (414.51 mM)H2

2、O : 40% PEG300 5% Tween-80 45% salineSolubility: 3.25 mg/mL (13.47 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 3.25 mg/mL (13.47 mM); Clear solution1/3 Master of Small Molecules 您边的抑制剂师www.MedChemEBIOLOGICAL ACTIVITY物活性 SU9516种有效的 CDK2 抑制剂,IC50 值为 22 nM,同时对 CDK1 和 CDK4 也有抑制作,IC

3、50 值分别为40 和 200 nM。IC50 & Target CDK2 CDK1 CDK4 PDGFr22 nM (IC50) 40 nM (IC50) 200 nM (IC50) 18000 nM (IC50)体外研究 SU9516 shows slight activities against PKC, p38, PDGFr and EGFR, with IC50 of 10, 10, 18, and 100 M. SU9516 (5 M) decreases cdk2-specific Phosphorylation of pRB and inhibits cell cycle pr

4、ogression inRKO cells. SU9516 (5 M) also induces apoptosis in RKO and SW480 Cells 1. SU9516 (5 M) results inenhanced pRb/E2F complex formation in HT-29 cells. SU9516 enhances presence of E2F species inmultiprotein complexes 2. SU9516 (5 M) rapidly induces cytochrome crelease, Bax mitochondrialtransl

5、ocation, and apoptosis in association with pronounced down-regulation of the antiapoptotic protein Mcl-1. SU9516 causes down-regulation of Mcl-1 mRNA levels in human leukemia cells. Furthermore, SU9516treatment results in a marked increase in reactive oxygen species production 3.PROTOCOLKinase Assay

6、 1 Kinase assays are performed in 96-well polypropylene plates. Each reaction contains 2 g of histone H1 at afinal concentration of 10 M -33PATP (0.2 Ci/well), 10 mM MgCl2,1mM DTT, 0.01% Triton X-100, and10% glycerol in a 40 L volume. The reaction is initiated with the addition of 20 L enzyme (6 ng

7、cdk2/wellresulting in a final concentration of 1.6 nM), which is previously diluted 1:50-1:200 in the same buffer, andallowed to proceed for 1 h at room temperature. Reaction is stopped by the addition of 0.01 mL 10%phosphoric acid, and 25 L of reaction mixture is transferred to P30 phosphocellulose

8、 filter mat paper. Thefilter mat is washed three times with 1.0% phosphoric acid, air dried, and then counted for radioactivity in aliquid scintillation counter.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Cell Assay 1 RKO cells and SW480 cells are s

9、eeded in replicates (n = 6) in 96-well plates at 1104 cells/well and allowedto attach overnight. SU9516 is added in concentrations from 0.05 M to 50.00 M for 24 h, the cells are thenwashed twice with PBS, and cells are replenished with complete media. The cells are fixed at 0, 4, and 7days post-drug

10、 removal and assayed for protein levels using a modified SRB cytotoxicity assay. The cells arefixed in 10% trichloroacetic acid for 1 h, washed in distilled H2O, and stained in 0.4% SRB/acetic acid for 30min. The cells are then washed in 0.1% acetic acid, solubilized in 10 mM Tris (pH 9), and analyz

11、ed on a Bio-Rad 360 microplate reader at 595 nm. All experiments are repeated at least three times.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 J Exp Clin Cancer Res. 2018 Feb 27;37(1):40.See more customer validations on HYPERLINK / www.M

12、edChemE2/3 Master of Small Molecules 您边的抑制剂师www.MedChemEREFERENCES1. Lane ME, et al. A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells. Cancer Res. 2001 Aug15;61(16):6170-7.2. Yu B, et al. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high

13、 molecular weight E2F complexes in humancolon carcinoma cells. Biochem Pharmacol. 2002 Oct 1;64(7):1091-100.3. Gao N, et al. The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-1-(3H-imidazol-4-yl)-meth-(Z)-ylidene-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism. MolPharmacol. 2006 Aug;70(2):645-55.Mc

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论